Ocumeda and Swiss health insurer KPT are entering into a new partnership aimed at further improving access to preventive eye care.

Ocumeda is expanding its C-level and thereby strengthening the foundation for further growth of the company. Dr. Greta Onken-Menke assumes the role of Chief Operating Officer effective immediately.

At Opti 2026, Ocumeda will present three new products that enable optometrists to further strengthen their role as the primary contact for eye care.

Our second medical Advisory Board Meeting took place on November 20, 2025.

The medical service of the eye check-up is now being scientifically examined by the University Medical Center Hamburg-Eppendorf (UKE), supported by Fielmann with €600,000.

ZEISS Vision Care announced today that it has entered into a definitive agreement to acquire a 10% stake in Ocumeda at a total company valuation of €100m from Fielmann Group

Platform bridges the gap between retail optics and ophthalmology with accessible services for the prevention of avoidable eye diseases.

As part of our first advisory board meeting, we had the opportunity to exchange ideas at the end of April with leading figures in ophthalmology and neurology.

Ocumeda and Fielmann are entering into a strategic partnership to provide people with easier access to eye care.

Venture Kick is the leading startup support program in Switzerland.

The team from RWTH Aachen and Ocumeda has developed an algorithm for the detection of glaucoma.

Unrecognized eye diseases can severely impair the vision of people. However, many residents of retirement homes neglect regular eye check-ups.